Literature DB >> 22683923

Silencing of Eps8 blocks migration and invasion in human glioblastoma cell lines.

Maria Grazia Cattaneo1, Elisa Cappellini, Lucia M Vicentini.   

Abstract

Glioblastoma multiforme (GBM) is the most malignant human primary brain tumor, and its infiltrative nature represents the leading cause for the failure of therapies and tumor recurrences. It is therefore crucial the knowledge of the molecular mechanisms underlying GBM invasion to identify novel therapeutic targets to limit motility. In this study, we evaluated the role of Epidermal growth factor receptor Pathway Substrate 8 (Eps8), a crucial regulator of the actin cytoskeleton dynamics accompanying cell motility and invasion, in GBM migration and invasiveness. We found that silencing of the protein by small interfering RNAs (siRNAs) abrogated the migratory and invasive capacity of three different human GBM cell lines both in 2-dimensional (2-D) and 3-dimensional (3-D) in vitro assays. The inhibitory effect on invasion was maintained independently by the migration mode utilized by the cells in our 3-D model, and was accompanied by an impaired formation of actin-based cytoskeletal protrusive structures. Our data propose Eps8 as a key molecule involved in the control of the intrinsic invasive behavior of GBM cells, and suggest that this protein might represent a useful target for the design of new drugs for the treatment of these tumors.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22683923     DOI: 10.1016/j.yexcr.2012.05.010

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  9 in total

1.  The effects of focal adhesion kinase on the motility, proliferation and apoptosis of Caco2 and SMMC-7721 cells.

Authors:  Ning Gao; Huimin He; Li Xiao; Xiaojie Gao; Hongyan Shi; Qiong Wu; Nan Xu; Yuqing Lei; Xigui Song; Yingchun Hou
Journal:  Med Oncol       Date:  2015-03-20       Impact factor: 3.064

2.  EPS8-mediated regulation of multiple myeloma cell growth and survival.

Authors:  Honghao Zhang; Lijuan Zhou; Weijun Zhou; Xiaoling Xie; Meirong Wu; Yiran Chen; Yuxing Hu; Jingwen Du; Yanjie He; Yuhua Li
Journal:  Am J Cancer Res       Date:  2019-08-01       Impact factor: 6.166

Review 3.  Systematic review of protein biomarkers of invasive behavior in glioblastoma.

Authors:  Eli T Sayegh; Gurvinder Kaur; Orin Bloch; Andrew T Parsa
Journal:  Mol Neurobiol       Date:  2013-11-24       Impact factor: 5.590

4.  A dual-function epidermal growth factor receptor pathway substrate 8 (Eps8)-derived peptide exhibits a potent cytotoxic T lymphocyte-activating effect and a specific inhibitory activity.

Authors:  Xiaoling Xie; Weijun Zhou; Yuxing Hu; Yiran Chen; Honghao Zhang; Yuhua Li
Journal:  Cell Death Dis       Date:  2018-03-07       Impact factor: 8.469

5.  Identification of HLA‑A*1101‑restricted cytotoxic T lymphocyte epitopes derived from epidermal growth factor pathway substrate number 8.

Authors:  Huifang Lu; Baishan Tang; Yanjie He; Weijun Zhou; Jielei Qiu; Yuhua Li
Journal:  Mol Med Rep       Date:  2016-10-25       Impact factor: 2.952

6.  EPS8 is a Potential Oncogene in Glioblastoma.

Authors:  Gang Yang; Yong-Bin Lu; Quan-Lin Guan
Journal:  Onco Targets Ther       Date:  2019-12-02       Impact factor: 4.147

7.  Effects and mechanisms of Eps8 on the biological behaviour of malignant tumours (Review).

Authors:  Kaili Luo; Lei Zhang; Yuan Liao; Hongyu Zhou; Hongying Yang; Min Luo; Chen Qing
Journal:  Oncol Rep       Date:  2021-01-07       Impact factor: 3.906

Review 8.  Multicellular 3D Models to Study Tumour-Stroma Interactions.

Authors:  Elisabetta Colombo; Maria Grazia Cattaneo
Journal:  Int J Mol Sci       Date:  2021-02-05       Impact factor: 5.923

9.  Inhibition of Chloride Intracellular Channel 1 (CLIC1) as Biguanide Class-Effect to Impair Human Glioblastoma Stem Cell Viability.

Authors:  Federica Barbieri; Roberto Würth; Alessandra Pattarozzi; Ivan Verduci; Chiara Mazzola; Maria G Cattaneo; Michele Tonelli; Agnese Solari; Adriana Bajetto; Antonio Daga; Lucia M Vicentini; Michele Mazzanti; Tullio Florio
Journal:  Front Pharmacol       Date:  2018-08-21       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.